Sick leave and disability pension in inflammatory bowel disease: A systematic review
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sick leave and disability pension in inflammatory bowel disease: A systematic review
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 8, Issue 11, Pages 1362-1377
Publisher
Oxford University Press (OUP)
Online
2014-07-05
DOI
10.1016/j.crohns.2014.06.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Canadian Digestive Health Foundation Public Impact Series. Inflammatory Bowel Disease in Canada: Incidence, Prevalence, and Direct and Indirect Economic Impact
- (2016) Richard N Fedorak et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
- (2016) Remo Panaccione et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Effect of Adalimumab on Work Productivity and Indirect Costs in Moderate to Severe Crohn’s Disease: A Meta-Analysis
- (2016) David G Binion et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Permanent Work Disability in Crohn's Disease
- (2013) Ashwin N Ananthakrishnan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2013) Alessandro Liberati ANNALS OF INTERNAL MEDICINE
- Predictors of Temporary and Permanent Work Disability in Patients With Inflammatory Bowel Disease
- (2013) Uwe Siebert et al. INFLAMMATORY BOWEL DISEASES
- The burden of inflammatory bowel disease in Europe
- (2013) Johan Burisch et al. Journal of Crohns & Colitis
- Patients With Ulcerative Colitis Miss More Days of Work Than the General Population, Even Following Colectomy
- (2012) Martin Neovius et al. GASTROENTEROLOGY
- Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
- (2012) Marte Lie Høivik et al. GUT
- Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial
- (2012) Edouard Louis et al. Journal of Crohns & Colitis
- The Self-Reported Health and Productivity Burden of Autoimmune Disorders at a Major Self-Insured Employer
- (2012) Harris Allen et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- The Employee Absenteeism Costs of Inflammatory Bowel Disease
- (2012) Candace Gunnarsson et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- The burden of inflammatory bowel disease on health care utilization and quality of life
- (2012) Ellinoora Nurmi et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab
- (2011) B. G. Feagan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review
- (2011) M M ter Wee et al. ANNALS OF THE RHEUMATIC DISEASES
- Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohnʼs disease
- (2011) Henrik Stjernman et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Development and validation of the Crohnʼs disease perceived work disability questionnaire
- (2011) Mercedes Vergara et al. INFLAMMATORY BOWEL DISEASES
- Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: Ten-year results from the IBSEN study
- (2011) Marte Lie Høivik et al. Journal of Crohns & Colitis
- Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn’s disease in the PRECiSE 2 study
- (2010) B. G. FEAGAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
- (2010) S. Lichtiger et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Linking Crohn's disease health status measurements with International Classification of Functioning, Disability and Health and vocational rehabilitation outcomes
- (2010) C Reichel et al. JOURNAL OF REHABILITATION MEDICINE
- The pharmacoeconomics of biologic therapy for IBD
- (2010) Russell D. Cohen Nature Reviews Gastroenterology & Hepatology
- Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohnʼs disease version
- (2009) Mercedes Vergara et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Intestinal Surgery for Crohn’s Disease: Predictors of Recovery, Quality of Life, and Costs
- (2009) Marco Scarpa et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease
- (2008) Margaret C. Reilly et al. CLINICAL THERAPEUTICS
- The Direct and Indirect Cost Burden of Crohnʼs Disease and Ulcerative Colitis
- (2008) Teresa B. Gibson et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Obesity status and sick leave: a systematic review
- (2008) K. Neovius et al. Obesity Reviews
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started